CLINICAL CORRELATES WITH MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETES - PRELIMINARY-RESULTS OF THE APPROPRIATE BLOOD-PRESSURE CONTROLIN DIABETES TRIAL
Rw. Schrier et Ro. Estacio, CLINICAL CORRELATES WITH MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETES - PRELIMINARY-RESULTS OF THE APPROPRIATE BLOOD-PRESSURE CONTROLIN DIABETES TRIAL, Nephrology, 2, 1996, pp. 51-54
Clinical correlates associated with urinary albumin excretion (UAE) in
non-insulin dependent diabetes (NIDDM) are less well known than in in
sulin dependent diabetes (IDDM). We therefore performed a cross sectio
nal study examining the relationships of clinical risk factors and dia
betic complications with UAE in 950 NIDDM patients. The UAE status was
classified into the following categories: (i) no albuminuria (<20 mu
mg/min), (ii) microalbuminuria (20-200 mu g/min); and (iii) overt albu
minuria (>200 mu g/min). iu Univariate and miltivariate analyses were
initially performed evaluating the associations between clinical risk
factors and UAE. Univariate and multivariate analyses were then perfor
med examining the relationships between UAE and the diabetic complicat
ions (retinopathy, neuropathy and cardiovascular disease). Using multi
variate logistic regression analyses controlling for diabetes duration
, glycosylated haemoglobin, gender and race, the most significant pred
ictors of microalbuminuria and overt albuminuria were systolic hyperte
nsion, increased body mass index (BMI), decreased high-density lipopro
tein (HDL) cholesterol, insulin use and smoking pack years. Univariate
and multivariate analyses evaluating the associations between UAE and
diabetic complications revealed that UAE was a strong predictor of re
tinopathy (odds ratio [OR]=1.31:95% confidence interval [CI]=1.05,1.66
), neuropathy (OR=1.47; CI=1.19,19.83), and cardiovascular diseases (O
R=1.28; CI=1.05,1.52). Thus, in the present study increases in UAE wer
e associated with retinopathy, neuropathy and cardiovascular disease.
Urinary albumin excretion may therefore be a marker of diffuse vascula
r disease in NIDDM. Aggressive treatment of smoking, cholesterol and h
ypertension may not only diminish UAE but may also play a significant
role in decreasing the other NIDDM vascular complications.